Trial intelligence / Profile preview

Tranexamic acid for postpartum hemorrhage after vaginal delivery

IRCT20091023002624N22Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: serum hemoglobin level, need of additional uterotonic agents and 3 more. Started Apr 2016; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on IRCT20091023002624N22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20091023002624N22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call